FCGR2B and in situ carcinoma: Despite the significantly lower CD32b expression on naive and IgMhi MZ-like B cells from females with CIS or MS compared with controls, and the capacity of TNF expression in these cells to be regulated by IgG-IC through CD32b, a functional outcome dependent on reduced CD32b was not detected.